Headillu Corporate

A successful and independent Corporation

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.

Boehringer Ingelheim - who we are

  • Our Vision

    Our Vision

    Value through Innovation is the central concept of our corporate vision. Together with the corporate culture concept "Lead & Learn", this is the driver of the corporate culture.

  • Organisation

    Organisation

    Get an overview of the major consolidated companies and our main business areas Human Pharmaceuticals and Animal Health.

  • Prof. Dr Dr Andreas Barner

    Management

    Boehringer Ingelheim is a family-owned company governed by the Board of Managing Directors.

  • Annual Report 2009

    Annual Reports

    Our Annual Reports inform about our Company, our Corporate Responsibility, our Research & Development, our Business and the Consolidated Financial Statements.

  • Financial Highlights

    Financial Highlights

    Net sales, Research & Development, Operating Income and Personnel Capacity: Boehringer Ingelheim has a stable and healthy financial situation with long term growth.

  • History

    History

    Trace the history of Boehringer Ingelheim from the earliest days to the present.

  • Corporate Responsibility

    Corporate Responsibility

    The ethical principles that have guided Boehringer Ingelheim for well over a century created a culture of corporate and social responsibility and commitment.

  • Environmental Health Safety

    Environment Health Safety

    Striving to ensure to be economically viable, Boehringer Ingelheim follows severe guiding principles for safety, quality and environmental protection.

  • Licensing & Partnering

    Licensing & Partnering

    Boehringer Ingelheim actively seeks international Licensing and Partnering opportunities based on innovation and therapeutic progress.